GHK-CU 100mg
GHK-Cu 100mg is a copper-binding peptide supplied in lyophilized form for controlled laboratory research. This GHK-Cu 100mg research compound is studied in experimental models involving peptide signaling, copper-binding interactions, and molecular processes related to tissue research. For Research Use Only. Not for human or animal use. Not FDA evaluated.
Tissue — Copper-Binding Peptide
The following compounds operate through distinct, non-overlapping mechanisms that complement this product's research pathways. Each is independently available from the General Peptide catalog.
AHK-Cu 100mg (Alanine-Histidine-Lysine Copper Complex) is a short copper-binding peptide supplied in lyophilized form for controlled laboratory research. It is studied in research models examining copper-peptide coordination, molecular binding,...
BPC-157 20mg is supplied as a lyophilized powder for controlled laboratory research. This BPC-157 20mg research compound is used in experimental studies examining peptide activity, cellular signaling, and tissue-related biological processes. Fo...
GLOW 70mg is a lyophilized peptide blend containing GHK-Cu 50mg, BPC-157 10mg, and TB-500 10mg. This GLOW blend is studied in controlled laboratory research examining peptide interactions, tissue remodeling pathways, cellular signaling, and ext...
KLOW 80mg is a lyophilized peptide blend containing GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, and KPV 10mg. This KLOW blend is studied in controlled laboratory research examining peptide interactions, cellular signaling, inflammatory pathways, an...